Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
979
datasets available to search
ShareScore release 0.9.0
Dataset results
979 results for “HR”
Pyrotinib Combined With Trastuzumab, Dalpiciclib, Letrozole Versus TCbHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HR +/HER2 + Breast Cancer
ClinicalTrials.gov study NCT05638594. IPD Sharing: NO. Countries: 1. Publications: 1.
APOSTrophe Study (Parenteral Nutrition and Bone Trophicity) Impact of a Long-term Parenteral Nutrition on Bone Metabolism Measured by High Resolution Peripheral Quantitative Computer Tomography (HR-pQ
ClinicalTrials.gov study NCT02368496. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Progression of Bone Erosions in Rheumatoid Arthritis Assessed by HR-pQCT and Conventional X-ray
ClinicalTrials.gov study NCT03429426. IPD Sharing: UNDECIDED. Countries: 1. Publications: 3.
500mg Fulvestrant in HR+ MBC
ClinicalTrials.gov study NCT03708432. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
A Study of SHR6390 in Combination With Letrozole or Anastrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
ClinicalTrials.gov study NCT03966898. IPD Sharing: NO. Countries: 1. Publications: 2.
Real-life Evaluation of Endopredict® in Early HR+/HER2- Breast Cancer
ClinicalTrials.gov study NCT07379918. IPD Sharing: NO. Countries: 0. Publications: 0.
β-blockers Withdrawal in Patients With HFpEF and Chronotropic Incompetence: Effect on Functional Capacity (Preserve-HR)
ClinicalTrials.gov study NCT03871803. IPD Sharing: NO. Countries: 1. Publications: 6.
Metronomic Treatment With Daily Oral Vinorelbine as First-line Chemotherapy in Patients With Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2
ClinicalTrials.gov study NCT03007992. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Asian Study of Sacituzumab Govitecan (IMMU-132) in HR+/HER2- Metastatic Breast Cancer (MBC)
ClinicalTrials.gov study NCT04639986. IPD Sharing: NO. Countries: 3. Publications: 2.
Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)
ClinicalTrials.gov study NCT04964934. IPD Sharing: YES. Countries: 23. Publications: 2.
Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer
ClinicalTrials.gov study NCT05503108. IPD Sharing: NO. Countries: 1. Publications: 4.
Variation in Food Intakes, Physical Activity, and Psychological Stress on Fluctuations in 24-hr Plasma Glucose Levels
ClinicalTrials.gov study NCT04522063. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study of SHR6390 in Combination With Fulvestrant in Patients With HR Positive and HER2 Negative Advanced Breast Cancer
ClinicalTrials.gov study NCT03927456. IPD Sharing: NO. Countries: 1. Publications: 2.
Clinical Trial to Measure the Maximun HR After ReConnect ® Supplementation vs. Placebo in CFS.
ClinicalTrials.gov study NCT02063126. IPD Sharing: Not stated. Countries: 1. Publications: 2.
NoL, HR and MABP Responses to Tracheal Intubation Performed With MAC Blade Versus Glidescope
ClinicalTrials.gov study NCT03277872. IPD Sharing: NO. Countries: 1. Publications: 1.
Effect of Paced HR on Central BP
ClinicalTrials.gov study NCT07078487. IPD Sharing: UNDECIDED. Countries: 1. Publications: 4.
Efficacy and Safety of Ribociclib in Pre- and Postmenopausal Chinese Women With HR Positive, HER2-negative, Advanced Breast Cancer.
ClinicalTrials.gov study NCT03671330. IPD Sharing: YES. Countries: 1. Publications: 0.
Study to Assess the Safety of Alpelisib Plus Fulvestrant, in Men and Post-menopausal Women With HR-positive, HER2-negative, Advanced Breast Cancer (aBC) With PIK3CA Mutation, Whose Disease Progressed
ClinicalTrials.gov study NCT05631795. IPD Sharing: YES. Countries: 1. Publications: 0.
Renal Denervation on Quality of 24-hr BP Control by Ultrasound In Resistant Hypertension
ClinicalTrials.gov study NCT02918305. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Assess Extent of Agreement Between Online 24-hr Dietary Recall and Interviewer-administered 24-hr Dietary Recall on the Same Day for 2 Non-consecutive 2 Days 1 wk Apart to Adults and School Age Childr
ClinicalTrials.gov study NCT04372160. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.